Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Sports Medicine and Physical Fitness|October 9, 2018
Effects of a home-based exercise rehabilitation program for cancer survivorsLaura Stefani, Riggs Klika, Gabriele Mascherini, et al.
Current Medicinal Chemistry|May 13, 2017
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side EffectLorenzo Antonuzzo, Alice Lunghi, Paolo Petreni, et al.
Lung Cancer (Amsterdam, Netherlands)|December 9, 2022
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classificationEnrico Caliman, Sara Fancelli, Giulia Petroni, et al.
Journal of Thoracic Disease|May 25, 2026
Post-operative outcomes of lung resection after perioperative chemoimmunotherapy for stage IIB-IIIB non-small-cell lung cancer in the elderly: a single center real-life experienceStefano Bongiolatti, Giovanni Mugnaini, Domenico Viggiano, et al.
Journal of Cell Science|October 6, 2012
Mechanism of polarized lysosome exocytosis in epithelial cellsJin Xu, Kimberly A Toops, Fernando Diaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptorKenkichi Baba, Nikita Pozdeyev, Francesca Mazzoni, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 2016
First-line treatment of NSCLC with bevacizumab: real world data from an Italian regional based surveyAndrea Camerini, Antonio Chella, Francesca Mazzoni, et al.
Scientific Reports|November 28, 2024
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitorsMartina Catalano, Sara Fancelli, Enrico Caliman, et al.
Current Cancer Drug Targets|September 1, 2022
Gender Matters. Sex-related Differences in Immunotherapy Outcome in Patients with Non-small Cell Lung CancerEnrico Caliman, Maria Cristina Petrella, Virginia Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 19, 2013
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancerFrancesca Mazzoni, Fabiana Letizia Cecere, Giulia Meoni, et al.
Pageof 11